Coronavirus Outbreak: US Food and Drug Administration says 72 COVID-19 therapeutics trials, 211 in planning stages underway
Seventy-two COVID trials of therapeutics are underway in the United States under FDA oversight and 211 are in the planning stages, so we expect to see more. This includes convalescent plasma as well as antiviral therapies
Washington: A top Trump administration health official has said that as many as 19 therapeutics trials are underway and 211 in planning stages in a bid to find the cure for coronavirus.
We are leaving no stone unturned to find the treatment for COVID-19... We don't have any approved therapeutics for COVID-19 but we are actively involved with the academic, commercial and private sector to find it, FDA Commissioner Stephen M Hahn told reporters at a White House news conference.
Seventy-two trials of therapeutics are underway in the United States under FDA oversight and 211 are in the planning stages, so we expect to see more. This includes convalescent plasma as well as antiviral therapies, Hahn added.
According to Hahn, work is continuing on finding a vaccine. FDA has authorised two firms on vaccine trials.
Hahn said that the FDA has told manufacturers that in order to market anti-body tests in the US, they have to validate their tests.
They have to tell us that they validated their tests, and in the package insert they have to let people know, end-users, labs, etc, that those tests were not authorised by FDA, he said.
So far, the US has authorised four and more are in the pipeline, he added.
Antibody tests that are used to detect natural immunity and the FDA's approach to help make these tests available, he noted.
These are just one part of the FDA's larger response effort. They can play a role in helping move the economy forward by helping healthcare professionals identify those who have immunity to the COVID-19, he asserted.
During the COVID-19 pandemic, the FDA has worked with more than 380 test developers who have said they will be submitting emergency use authorisations (EUA) requests to FDA for tests that detect the virus.
To date, the FDA has issued 44 individual emergency use authorisations for test kit manufacturers and laboratories.
In addition, 19 authorised tests have been added to the EUA letter of authorisation for high complexity molecular-based laboratory-developed tests (LDTs).
Trump, 76, is seeking a potential rematch with Democratic President Biden
Donald Trump has formally announced his bid for the 2024 US presidential election. But this time it will be more difficult for him. His biggest rival is Florida Governor Ron DeSantis, but he might not the only Republican who hopes to beat the former president to set up a White House run
Justice Arthur Engoron of the Manhattan Supreme Court set a trial date of 2 October, 2023 in the case that alleges Trump and his family members misstated the value of properties to enrich themselves